The effect size of type 2 diabetes mellitus on tuberculosis drug resistance and adverse treatment outcomes
- 1 March 2017
- journal article
- Published by Elsevier in Tuberculosis
- Vol. 103, 83-91
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomesThorax, 2012
- The impact of diabetes on tuberculosis treatment outcomes: A systematic reviewBMC Medicine, 2011
- Nutrition, Diabetes and Tuberculosis in the Epidemiological TransitionPLOS ONE, 2011
- Diabetes mellitus and tuberculosis in countries with high tuberculosis burdens: individual risks and social determinantsInternational Journal of Epidemiology, 2011
- Pharmacokinetics of Antituberculosis Drugs in Pulmonary Tuberculosis Patients with Type 2 DiabetesAntimicrobial Agents and Chemotherapy, 2010
- Tuberculosis and diabetes mellitus: convergence of two epidemicsThe Lancet Infectious Diseases, 2009
- Diabetes Mellitus Increases the Risk of Active Tuberculosis: A Systematic Review of 13 Observational StudiesPLOS Medicine, 2008
- Type 2 diabetes and multidrug-resistant tuberculosisScandinavian Journal of Infectious Diseases, 2008
- Pharmacokinetics and Tolerability of a Higher Rifampin Dose versus the Standard Dose in Pulmonary Tuberculosis PatientsAntimicrobial Agents and Chemotherapy, 2007
- Survival Analysis Part II: Multivariate data analysis – an introduction to concepts and methodsBritish Journal of Cancer, 2003